Long Term Growth review of Horizon Pharma plc (NASDAQ:HZNP)
- Author: Joanne Flowers Jun 17, 2017,
Jun 17, 2017, 1:32
Piper Jaffray Companies cut their price target on shares of Horizon Pharma PLC from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Friday, March 24th.
In Railroads Industry, Union Pacific Corporation (UNP) have 811.50 million outstanding shares now held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders. Deerfield Management Co. boosted its position in shares of Horizon Pharma PLC by 39.2% in the fourth quarter. Four research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. 3,572,487 shares of the stock traded hands.
TRADEMARK VIOLATION WARNING: "Horizon Pharma PLC (HZNP) Downgraded to Neutral at Mizuho" was reported by Community Financial News and is the sole property of of Community Financial News. It has underperformed by 44.83% the S&P500.The move comes after 5 months positive chart setup for the $1.70B company. Manufacturers Life Insur Company The reported 0% of its portfolio in Curis, Inc. The Firm provides software for video advertising effectiveness. A negative earnings surprise will usually result in a decline in share price.
Horizon Pharma Ord (NASDAQ:HZNP) has average revenue estimates of $236.47 Million, compared to low analyst estimates of $230.97 Million and high estimates of $242.7 Million for the current quarter. Therefore 56% are positive. Deerfield Management Co. now owns 8,956,988 shares of the biopharmaceutical company's stock worth $144,924,000 after buying an additional 2,522,549 shares during the last quarter. BMO Capital Markets restated a "buy" rating and set a $17.00 price objective (down from $24.00) on shares of Horizon Pharma PLC in a research report on Tuesday, May 9th. As per Friday, February 10, the company rating was initiated by Susquehanna. The stock has "Buy" rating by Mizuho on Monday, October 31. The firm earned "Outperform" rating on Friday, January 6 by Robert W. Baird. The rating was downgraded by Mizuho on Tuesday, May 9 to "Neutral". The firm earned "Equal-Weight" rating on Monday, November 2 by Morgan Stanley.
According to the latest data, investors are looking at Horizon Pharma Public Limited Company (NASDAQ:HZNP)'s short data and trying to figure out market sentiment on which way the market thinks the stock is moving. Its down 0.05, from 0.85 in 2016Q3.
Horizon Pharma plc (NASDAQ:HZNP). Finally, Dimensional Fund Advisors LP boosted its position in shares of Horizon Pharma PLC by 10.2% in the first quarter. The analysts estimated EPS for the higher end at 0.22 and lower end at 0.08 while the year ago reported earnings per share was 0.57. Kcg Holdings accumulated 17,453 shares or 0.01% of the stock. Envestnet Asset Mgmt owns 120,714 shares. Boston Private Wealth Limited Liability holds 1.55% or 279,479 shares in its portfolio. Vanguard Group Incorporated reported 0.01% stake. The New York-based Jw Asset Management Llc has invested 5.46% in the stock.
Shares of Horizon Pharma Ord (NASDAQ:HZNP) now have an Average Brokerage Recommendation of 1.67, number of Recs in ABR is 6 while industry rank of the company by ABR is 165 out of 265. Sei Invs Company invested in 0.02% or 200,993 shares. Commonwealth Equity Service reported 15,723 shares. Wells Fargo And Co Mn owns 443,109 shares for 0% of their portfolio. 390 were accumulated by First Personal. One Trading Ltd Partnership owns 229,284 shares for 0.04% of their portfolio. Closely-held shares are those owned by insiders, major shareholders and employees, while restricted stock refers to insider shares that can not be traded because of a temporary restriction such as the lock-up period after an initial public offering. Franklin Resources Inc reported 1.31M shares stake. Johnson & Johnson (NYSE:JNJ) was raised too.
Since February 28, 2017, it had 1 buy, and 1 insider sale for $414,996 activity. Tcw Group Inc sold 51,235 shares as the company's stock declined 38.11% while stock markets rallied. GREY MICHAEL G bought 10,000 shares worth $94,800.
News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Pharma, Inc. with MarketBeat.com's FREE daily email newsletter.